Salix, Cosmo cancel merger amid inversion crackdown
October 03, 2014 at 03:44 AM EDT
Salix and the Italian parent of drug maker Cosmo have ended a merger deal that had been structured as a so-called inversion, which has come under increased scrutiny in Washington and elsewhere.